e-learning
resources
Vienna 2012
Monday, 03.09.2012
Recent progress in mechanisms and diagnostics of COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Preliminary results from newborn screening
J. Chorostowska-Wynimko, R. Struniawski, B. Poplawska, M. Borszewska-Kornacka (Warsaw, Poland)
Source:
Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Session:
Recent progress in mechanisms and diagnostics of COPD and asthma
Session type:
Poster Discussion
Number:
1753
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Chorostowska-Wynimko, R. Struniawski, B. Poplawska, M. Borszewska-Kornacka (Warsaw, Poland). The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Preliminary results from newborn screening. Eur Respir J 2012; 40: Suppl. 56, 1753
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population - results from large scale newborn screening
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0
Ourém
mutation: A clinical characterization
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010
Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report
Source: Eur Respir J 2005; 26: Suppl. 49, 440s
Year: 2005
Tracing down the evolutionary history of Q0
Ourém
, a rare allele associated with severe alpha-1-antitrypsin deficiency (AATD)
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Frequency of α-1 antitrypsin deficiency (AATD) in a population screening in an high risk area (Val Trompia, Italy)
Source: Eur Respir J 2006; 28: Suppl. 50, 453s
Year: 2006
The
BTNL2
a allele variant is frequent in Danish patients with sarcoidosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
Screening surfactant protein genes in patients with hereditary pulmonary surfactant deficiency – UK experience
Source: Annual Congress 2009 - Respiratory disorders of the newborn
Year: 2009
Overdiagnosis of severe asthma – single centre study. Preliminary results
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ)
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006
Health status changes in alpha-1-antitrypsin deficiency (PiZ phenotype) over 3 years
Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD
Year: 2003
Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Estimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countries
Source: Eur Respir J 2006; 27: 77-84
Year: 2006
The incidence of severe alpha-1-antitrypsin (AAT) deficiency alleles in COPD patients – Preliminary results from Central Eastern European (CEE) AAT NETWORK
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Characterization of a population of alpha
1
-antitrypsin deficient (A
1
ATD) patients
Source: Annual Congress 2008 - COPD
Year: 2008
The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database
Source: Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept